Discrete Wavelet Transform-Based Whole-Spectral and Subspectral Analysis for Improved Brain Tumor Clustering Using Single Voxel MR Spectroscopy by Yang, G. et al.
Yang, G., Nawaz, T., Barrick, T. R., Howe, F. A. & Slabaugh, G.G. (2015). Discrete Wavelet 
Transform-Based Whole-Spectral and Subspectral Analysis for Improved Brain Tumor Clustering 
Using Single Voxel MR Spectroscopy. IEEE Transactions on Biomedical Engineering, 62(12), pp. 
2860-2866. doi: 10.1109/TBME.2015.2448232 
City Research Online
Original citation: Yang, G., Nawaz, T., Barrick, T. R., Howe, F. A. & Slabaugh, G.G. (2015). 
Discrete Wavelet Transform-Based Whole-Spectral and Subspectral Analysis for Improved Brain 
Tumor Clustering Using Single Voxel MR Spectroscopy. IEEE Transactions on Biomedical 
Engineering, 62(12), pp. 2860-2866. doi: 10.1109/TBME.2015.2448232 
Permanent City Research Online URL: http://openaccess.city.ac.uk/14029/
 
Copyright & reuse
City University London has developed City Research Online so that its users may access the 
research outputs of City University London's staff. Copyright © and Moral Rights for this paper are 
retained by the individual author(s) and/ or other copyright holders.  All material in City Research 
Online is checked for eligibility for copyright before being made available in the live archive. URLs 
from City Research Online may be freely distributed and linked to from other web pages. 
Versions of research
The version in City Research Online may differ from the final published version. Users are advised 
to check the Permanent City Research Online URL above for the status of the paper.
Enquiries
If you have any enquiries about any aspect of City Research Online, or if you wish to make contact 
with the author(s) of this paper, please email the team at publications@city.ac.uk.
TBME-00140-2015  
 
Abstract—Many approaches have been considered for 
automatic grading of brain tumours by means of pattern 
recognition with magnetic resonance spectroscopy (MRS). 
Providing an improved technique which can assist clinicians in 
accurately identifying brain tumour grades is our main 
objective. The proposed technique, which is based on the 
discrete wavelet transform (DWT) of whole-spectral or sub-
spectral information of key metabolites, combined with 
unsupervised learning, inspects the separability of the extracted 
wavelet features from the MRS signal to aid the clustering. In 
total, we included 134 short echo time single voxel MRS spectra 
(SV MRS) in our study that cover normal controls, low grade 
and high grade tumours. The combination of DWT-based 
whole-spectral or sub-spectral analysis and unsupervised 
clustering achieved an overall clustering accuracy of 94.8% and 
a balanced error rate of 7.8%. To the best of our knowledge, it 
is the first study using DWT combined with unsupervised 
learning to cluster brain SV MRS. Instead of dimensionality 
reduction on SV MRS or feature selection using model fitting, 
our study provides an alternative method of extracting features 
to obtain promising clustering results. 
 
Index Terms—Brain tumour, glioma grade, clustering, 
dimension reduction, discrete wavelet transform, magnetic 
resonance spectroscopy, unsupervised learning.      
I. INTRODUCTION 
    Magnetic resonance imaging (MRI) is a widely-used 
modality that facilitates the diagnosis and prognosis of brain 
tumours. Standard MRI sequences are routinely used to 
differentiate among various brain tumour types based on 
qualitative visual analyses of the represented soft tissue 
contrast. Indeed, more than 120 classes of brain tumours are 
known [1], which are categorised into four grades depending 
on the level of malignancy by the world health organisation 
(WHO) [2]. The grading from low to high (I-IV) represents 
malignancy levels from biologically least aggressive to most 
aggressive brain tumours as shown by histological criteria, 
e.g., invasiveness, vascularity, and tumour growth rate [1]. 
Gliomas are the most common primary brain tumour and 
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pre-treatment assessment of grade is required; however, the 
sole use of standard MRI sequences may be insufficient for 
an accurate diagnosis [3]. The current gold standard for 
diagnosis of a suspicious abnormal mass is the 
histopathological analysis of a biopsy sample [4]. However, 
due to tumour heterogeneity a tumour may be under-graded 
if the area of greatest malignancy is not selected for biopsy. 
    Alternatively, in-vivo 1H magnetic resonance 
spectroscopy (MRS) can be used to non-invasively inspect 
the biochemical information of the metabolites present in the 
living tissue, and can improve characterisation of human 
brain tumours compared to using standard MRI alone. There 
are up to 12 different metabolites in the brain that can be 
measured using 1H MRS at clinical field strengths of 1.5T or 
3T [5]. In particular, single voxel (SV) MRS extracts 
metabolic information of a specific region of interest (ROI), 
and it is a unique non-invasive tool to aid classification of 
human brain tumours with appropriate spectral analysis such 
as with pattern recognition [6].  
    Analysis of 1H MRS data for data clustering and tissue 
classification generally requires some form of data 
reduction, either to reduce the noise or extract the most 
salient features. Mainardi et al. [7] designed a quantification 
model for in-vivo MRS parameters using the discrete 
wavelet packet decomposition (WPD). Mahmoodabadi et al. 
proposed a modified frequency ordered WPD method 
combined with fuzzy classification framework to analyse 
pediatric metabolic brain diseases using wavelet transform 
based features extracted from both MRS and diffusion-
weighted imaging [8]. Tiwari et al. investigated combining 
wavelet (Gabor and Haar filters) features extracted from 
both T2-weighted MRI and MRS modalities, applied to 
supervised prostate cancer detection [9]. The discrete 
wavelet transform (DWT) has the advantage of providing 
multi-resolution discriminatory information [10] from 
different acquisition modalities, including but not limited to 
digital signals and images [9]. However, there is very limited 
research in the literature on fully-automating an 
unsupervised brain tumour data clustering using DWT based 
analysis that does not require labelled data or incur possible 
overfitting during the training procedure.        
    Here we hypothesise that unsupervised learning based 
clustering on extracted DWT features can improve brain 
tumour grading compared to dimension reduction 
techniques, which are based on second and higher-order 
statistics (e.g., PCA and ICA) or manifold learning based 
nonlinear methods (e.g., Laplacian Eigenmaps (LE)). We 
extract DWT features of the whole-spectra and sub-spectra 
(as shown in Figure 1), and hypothesise that local 
information from only a few key metabolites of the sub-
spectra is sufficient to distinguish between tumour grades, 
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because those metabolites exhibit discriminative 
characteristics for specific tumour grades [6]. 
To accomplish this, we build a feature vector by using the 
DWT coefficients of the whole-spectra or by encoding the 
non-parametric statistics of the computed DWT coefficients 
of the sub-spectra corresponding to different metabolites. 
Then in an agglomerative hierarchical clustering framework 
the MR spectra belonging to different tumour grades are 
separated. We show the effectiveness of the proposed 
method on SV MRS data (134 spectra), acquired from 
normal brain tissue and from low and high grade gliomas. 
The proposed methods show encouraging performance by 
achieving an unsupervised clustering accuracy of 94.8% for 
both whole-spectral and sub-spectral analysis that 
outperforms our previous analyses of this data. Instead of 
extracting eigen-decomposed features using dimensionality 
reduction techniques, this study explores DWT features 
using whole-spectral and sub-spectral analysis, and obtains 
promising clustering results for separating different brain 
tissue types. Section II details the materials and main 
methods of this study. Section III demonstrates our 
experimental results followed by elaborated discussions 
(Section IV) and a conclusion (Section V). 
 
 
Figure 1: Decomposition of a whole MR spectrum into a set of sub-spectra 
(sub-regions coloured in cyan) corresponding to different metabolites. 
Representative Grade II (GII) tumour, Grade IV (GIV) tumour and Normal 
spectra are shown in blue, red and green colours. The selected features 
using mRMR are shown with magenta circles. 
II. MATERIALS AND METHODS 
A. Data Acquisition and Patient Subjects 
    MR data were obtained at St. George’s University of 
London using a 1.5-Tesla scanner (GE Healthcare, 
Milwaukee, WI, USA), which was equipped with 22      
gradients and a quadrature head coil. Written informed 
consent was obtained from all participants in accordance 
with local ethics procedures. Either biopsy or resected 
tumour tissue samples obtained as part of the patients’ 
clinical diagnosis or treatment were used to provide a 
histological diagnosis of the tumour type and grade as the 
overall gold standard (ground truth). 
     In total       SV MRS were obtained including 24 
Grade II (GII) tumours (2 oligodendroglioma, 3 
oligoastrocytoma, 3 ﬁbrillary astrocytoma, 4 gemistocytic 
astrocytoma and 12 diffuse astrocytoma) and 31 Grade IV 
(GIV, glioblastoma multiforme). A further 79 MR spectra 
were obtained from three normal controls using multiple 
voxel MRS with the same acquisition parameters (i.e., which 
had compatible TR/TE) as the SV MRS (Table 1). 
 
TABLE 1 
NUMBER OF PATIENTS STUDIED AND NUMBER OF SPECTROSCOPIC 
VOXELS ANALYSED FOR EACH TISSUE CLASS. 
  
Tissue Class   
Normal Grade II Grade IV Total 
Number of Subjects Studied 3 24 31 58 
Number of MRS Voxels Analysed 79 24 31 134 
 
    All SV MRS data were acquired at short Echo Time (TE) 
using the GE developed point-resolved spectroscopic 
sequence (PRESS) protocol (Repetition Time (TR) = 
2000ms, Echo time (TE) = 30ms, 2048 data points with 
2500Hz bandwidth). 
     An expert panel (including spectroscopists, pathologists 
and radiologists) validated the brain tissue types included in 
this study as part of the eTUMOUR project, with a 
histopathological diagnosis of the central nervous system 
(CNS) tumours according to WHO criteria [2]. Individual 
voxels were placed to encompass predominantly viable 
tumour tissue as much as possible and avoid areas of pure 
necrosis. Apodisation in the time domain was performed 
using a half Hann window followed by a fast Fourier 
transform and automatic phasing according to [11]. Each 
spectrum was referenced to both N-acetyl Aspartate (NAA 
at 2ppm and a search region                ) and 
Choline (Cho at 3.21ppm and a search region                ) for chemical shift alignment, and then truncated to 
the chemical shift range of 4.0 to 0.2ppm. In addition, the 
phased real part of the spectra were used for further analysis 
[12]–[14]. Each whole spectrum consisted of       data 
points representing the majority of metabolic information. 
B. Feature Extraction 
All SV MRS data were stored as a 2D matrix,       , 
where                contains each spectrum as a 
column vector      . The column vectors were    
normalised, 
       √∑             {       }                                                                            
 
to form the matrix    {   }     with        , which is a 
set of normalised MR spectra.   is the number of the spectra 
and  is the number of the data points of each spectrum. 
    We used the DWT to encode the MR spectral information. 
For both the whole-spectral and sub-spectral analysis, we 
compared widely-used wavelet basis functions including 
Daubechies (Db1, Db2, Db3), Coiflets (Coif1, Coif2, Coif3) 
and Symlets (Sym1, Sym2, Sym3).  
    For the whole-spectral analysis, we tested multiple levels 
(i.e., 1 to 12 levels) of decomposition. At each level of 
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resolution or octave, the spectral signal     is convolved ( ) 
simultaneously with a high-pass filter (  ) and a low-pass 
filter (  ) to obtain the corresponding coefficients (   and   ) as               and                with the 
subsampling or decimation ( ) by a factor of 2 after each 
pass through the paired filters [15]. The feature vectors are 
computed for all     to obtain the feature matrix, of size       , in which    is the size of the approximation and 
detail coefficients at different levels           (Table 2). 
    For the sub-spectral analysis by given     we built the 
feature vector,   , as follows. We extracted information for 
the key metabolites by taking the sub-spectra windowed 
symmetrically around their respective ppms (Figure 1).  We 
performed a mutual information based feature selection (i.e., 
mRMR, minimum redundancy and maximum relevance 
method [16]) to identify the key metabolites, which are the 
most powerful discriminants in terms of separating the three 
tissue types (Normal, GII and GIV). The only parameter 
specified in the mRMR method is the number of features, 
which was set to 10 in order to obtain a moderate sample per 
feature ratio to avoid overfitting [17]. The mRMR method 
resulted in 10 selected features (Figure 1) at 3.62, 3.24, 2.99, 
2.49, 2.05, 2.03, 2.01, 1.99, 1.19, and 0.85 ppm. For sub-
spectral analysis we chose dominant high signal to noise 
ratio biochemicals [18] whose peak areas are mostly 
strongly associated with these regions: NAA (main singlet at 
2.05 ppm), Cho (3.21 ppm), Creatine (Cr) (3.02 ppm) and 
lipids and macromolecules (main peaks at 1.3 and 0.9 ppm). 
The excluded points of 3.62 ppm and 2.49 ppm include 
strongly overlapping multiplet peaks from Myo-inositol with 
glutamate and glutamine (Glx) and those from Glx with 
NAA respectively. Note in high-grade tumours there may 
also be a contribution from lactate (doublet centred at 1.33 
ppm). Boxplots of the five selected features among three 
different tissue types are shown in Figure 2, and statistical 
significances were given by two-sample Wilcoxon rank-sum 
test between each two tissue types (significance level of 
p<0.01 subject to the Bonferroni correction [19]). In general, 
NAA and Cr are decreased and Cho increased in tumours 
compared to normal brain [20]. Additionally, the Lipid and 
lactate signal observable at short TE increase with tumour 
grade [20]. The sub-spectra for NAA, Cho, Cr, Lipid (0.9 
ppm) and Lipid and Lactate (1.3 ppm) were denoted as       ,       ,      ,        , and        , respectively. The 
window sizes for each     were fixed and denoted as     ,     ,    ,      , and      , respectively. We applied the 
DWT using the single-level implementation of Mallat's 
approach [10] on each of the       ,       ,      ,        , and         signals to obtain the corresponding set of 
(approximation and detail) coefficients      ,      ,     ,       ,       , respectively. The higher levels of 
decomposition were not needed given the smaller sub-
spectra window sizes compared to the whole-spectral 
analysis, and single-level decomposition was expected to be 
sufficient to effectively capture the frequency information. 
 
 
Figure 2: Boxplot of the five selected features among three tissue types 
(Normal: green; GII: blue; GIV: red). Red circled dots are the outliers of 
each group (*** indicates p<0.0001 and ** indicates p<0.001).    
    The choice of the window sizes ( ) for different 
metabolites can influence the performance of the system. In 
addition, the window size must be kept small to avoid 
TABLE 2 
PARAMETER SETTINGS OF THE DWT METHOD USING WHOLE-SPECTRAL ANALYSIS AND SUB-SPECTRAL ANALYSIS (WBF: WAVELET BASIS FUNCTIONS; LD: 
LEVEL OF DECOMPOSITION). BOLD TEXT INDICATES THE BEST PARAMETER SETTINGS. 
Whole-spectral WF LD Accuracy (Mean ± Standard Deviation) Best Accuracy  (with WF and LD Settings)  
  
Daubechies 
(DbAll) 
Db1 [1-12] 83.1% ± 1.6% 
94.8% (with Db1 and 7 levels of decomposition) Db2 [1-12] 82.5% ± 2.1% 
Db3 [1-12] 78.3% ± 2.5% 
Coiflets 
(CoifAll) 
Coif1 [1-12] 81.0% ± 2.5% 
94.8% (with Coif1 and 6 levels of decomposition) Coif2 [1-12] 83.2% ± 1.6% 
Coif3 [1-12] 79.8% ± 2.2% 
Symlets 
(SymAll) 
Sym1 [1-12] 83.2% ± 1.6% 
92.5% (with Sym1 and 7 or 9 levels of decomposition) Sym2 [1-12] 83.2% ± 1.6% 
Sym3 [1-12] 83.1% ± 1.6% 
      
Sub-spectral WF LD Window Sizes for Each Metabolite Best Accuracy  (with WF and WS) 
  
Daubechies 
Db1 1 
ω=[0.02ppm,0.04ppm,…,0.28ppm,0.30ppm] 
94.8% 
(with Coif1 and ωNAA=0.16ppm, ωCho=0.16ppm, 
ωCr=0.04ppm, ωLip1=0.18ppm, and ωLip2=0.20ppm) 
Db2 1 
Db3 1 
Coiflets 
Coif1 1 
Coif2 1 
Coif3 1 
Symlets 
Sym1 1 
Sym2 1 
Sym3 1 
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overlap between of adjacent metabolites, and we also need 
enough data points for further data clustering. We analysed 
the effect of the variation that                                      , i.e., 15 sets of 
window sizes [-0.01ppm, 0.01ppm], [-0.02ppm, 
0.02ppm],…, [-0.14ppm, 0.14ppm], [-0.15ppm, 0.15ppm 
around each peak of the metabolites) with respect to 
clustering performance (Table 2). The window size for each 
metabolite was varied in turn with the window sizes of the 
remaining metabolites kept fixed, and inherent to this 
process is the assumption that the window sizes are 
independent in terms of optimisation. The first key 
metabolite was Cho (centred at 3.21ppm) and the window 
was varied with window size for the other metabolites fixed 
at the initial smallest value. Subsequently, the window sizes 
for Cr centred at 3.02 ppm, NAA at 2 ppm, Lip2 at 1.3 ppm, 
and Lip1 at 0.9ppm were optimized in turn. 
    Inspired by [21], we further encapsulated the distribution 
of the computed DWT coefficients non-parametrically for a 
metabolite, e.g., NAA, as follows: 
       {                                                      }        
 
where       denotes the feature vector that encodes the non-
parametric statistics for the DWT coefficients (     ) of        using the minimum coefficient value (   (     )), 
25th percentile (   (     )), 50th percentile (   (     )), 
75th percentile (   (     )), and the maximum coefficient 
value (   (     )).       comprehensively captures the 
information of        by encoding the overall distribution of 
its coefficients [21]. Similarly to Equation 2, the feature 
vectors for       ,      ,        , and         can be computed 
and denoted as     ,      ,       ,       , respectively. The 
feature vector,   , is therefore defined as follows: 
    {                               }                                                                                 
 
and    is a 25-dimensional row vector. Using Equation 3 the 
feature vectors are computed for all     to obtain the feature 
matrix, of size       .  
    Unsupervised learning based hierarchical clustering is 
then performed on the feature matrix extracted using whole-
spectral or sub-spectral analysis as described below. 
C. Data Clustering 
    To quantitatively validate and compare the efficacy of our 
DWT based feature extraction method to previous studies, 
we applied agglomerative hierarchical clustering algorithms 
to the feature extraction outputs. Compared to widely used 
k-means clustering, hierarchical clustering requires no 
initialisation settings, and thus can avoid possible local 
minima that could trap the k-means algorithm.   
    For hierarchical clustering a dissimilarity measure was 
specified (the Euclidean distance) between disjoint groups of 
observations according to pairwise dissimilarities between 
the observations in the two groups. An agglomerative (i.e., 
bottom-up) paradigm was used which recursively merges 
pairs of clusters into a single cluster at each level [22]. Pairs 
were merged based on the smallest inter-group dissimilarity 
and representation of the recursive binary agglomeration was 
achieved using dendrograms (i.e., rooted binary trees). 
 
Figure 3: Comparison between different wavelet basis functions in terms of 
the obtained clustering accuracy (A) for both whole-spectral and sub-
spectral analysis. Error bars represent the standard error of the mean (SEM). 
For the whole-spectral analysis, SEM was calculated with respect to 
different decomposition levels. For the sub-spectral analysis, SEM was 
computed with respect to various window sizes. Circles above the error bars 
indicate the maximum accuracy achieved by different wavelet basis 
functions.    
D. Performance Assessment 
    We evaluated the performance of the proposed method 
from a clinical point of view using the following measures: 
precision ( ), recall/sensitivity   ), F-score ( ) and 
clustering accuracy ( ).           where    and    are the 
number of true positives (correct estimations) and false 
positives (incorrect estimations).           where    is the 
number of false negatives (missed estimations). In addition,          . Furthermore,   provides the overall clustering 
accuracy as a ratio of the number of correct clustering 
(        ) and total number of input spectra ( ) that is            .                  , and the higher 
TABLE 3 
PERFORMANCE COMPARISON OF THE PROPOSED DWT METHOD (WHOLE-SPECTRAL ANALYSIS USING COIF1 WITH 6 LEVELS OF DECOMPOSITION OR SUB-
SPECTRAL ANALYSIS USING COIF1 WITH 1 LEVEL OF DECOMPOSITION) WITH PCA, PCA+ICA AND NONLINEAR LE METHODS. 
 
Method Brain Tissue  Types 
Predicted Group Membership Precision  
(P) 
Recall  
(R) 
F-Score  
(F) 
Accuracy  
(A) 
Silhouette Statistics 
(μSW ± σSW) BER Normal GII GIV 
PCA 
Normal 71 8 0 1.00 0.90 0.95 
0.873 0.521±0.230 0.140 GII 0 21 3 0.60 0.88 0.71 
GIV 0 6 25 0.89 0.81 0.85 
PCA+ICA 
Normal 79 0 0 1.00 1.00 1.00 
0.933 0.551±0.213 0.106 GII 0 21 3 0.78 0.88 0.82 
GIV 0 6 25 0.89 0.81 0.85 
LE 
Normal 79 0 0 1.00 1.00 1.00 
0.933 0.612±0.201 0.106 GII 0 21 3 0.78 0.88 0.82 
GIV 0 6 25 0.89 0.81 0.85 
DWT 
Normal 79 0 0 1.00 1.00 1.00 
0.948 0.743±0.278 0.078 GII 0 23 1 0.79 0.96 0.87 
GIV 0 6 25 0.96 0.81 0.88 
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           , the better the performance. In addition, we 
also calculated the balanced error rate [23] (BER), which is 
the average of the errors on each class, and is suitable for 
unbalanced datasets. 
We also evaluated the discriminative ability of the feature 
vector,   , in terms of quantifying intra-cluster tightness and 
inter-cluster separability. To this end we used the silhouette 
statistics that is computed for the  -th data point as follows 
[24]:                             , where    is the average distance 
of the  -th data point to the remaining points within the same 
cluster and    is the minimum average distance of the  -th 
data point to any of the remaining clusters. We used the 
mean (   ) and the standard deviation (   ) of     values 
as performance indicators. Higher      with lower     
indicate better partitioning of the clustering results and 
hence the better discriminative ability of the feature used.         indicates a proper partitioning whereas         indicates an improper partitioning [24]. 
III. RESULTS 
    Figure 3 shows the comparison of the widely-used 
wavelet basis functions based on the clustering accuracy ( ) 
for both whole-spectral and sub-spectra analysis. Examples 
of using Daubechies (Db1, Db2, Db3), Coiflets (Coif1, 
Coif2, Coif3) and Symlets (Sym1, Sym2, Sym3) of the 
whole spectra are shown as DbAll, CoifAll and SymAll. For 
the whole spectra, we tested multiple levels of 
decomposition with standard error of the mean (SEM) 
shown in the Figure 3. The minimum accuracy (40.3%) was 
obtained using Coif1 with 3 levels of decomposition while 
the maximum accuracy (94.8%) was achieved by Coif1 
using 6 levels or Db1 using 7 levels of decomposition (Table 
2). The Coif1 basis function achieved the highest clustering 
accuracy with a low level of decomposition, hence this 
represents the best option for the whole-spectral analysis. In 
addition, for the sub-spectral analysis, we display the SEM 
with respect to various window sizes (Figure 3). We tested 
different values for     ,     ,    ,      , and       as 
aforementioned to maximise clustering accuracy for each 
wavelet basis function. In so doing, we obtained the best 
clustering accuracy (94.8% in Table 2) using the Coif1 basis 
function with window sizes found to be      0.16ppm,      0.16ppm,     0.04ppm,       0.18ppm and       0.20ppm, respectively. The whole-spectral analysis 
(using Coif1 basis function with 6 levels of decomposition) 
and sub-spectral analysis (using Coif1 with 1 level of 
decomposition) performed identically (Table 2). For the 
whole-spectral analysis, clustering accuracies obtained by 
the Coif1 basis function with different decomposition levels 
showed no significant difference compared to the results of 
using the Db1 basis function, but showed significant 
differences compared to the results of other basis functions. 
For the sub-spectral analysis, clustering accuracies obtained 
by the Coif1 basis function with various window sizes 
showed significant differences compared to the results of 
using other basis functions (Non-parametric Kruskal-Wallis 
test with Dunn’s multiple comparisons was performed with a 
significance level of p<0.05). 
    Comparison results between DWT and other methods are 
provided quantitatively (Table 3). From a clinical point of 
view, the whole (6 levels of decomposition) and sub-spectral 
(1 level of decomposition) DWT method using Coif1 (from 
this point onwards referred to as the proposed DWT method 
with the best settings as seen in Table 2) showed the best 
performance for GII, GIV and Normal spectra, as reflected 
by its highest precision ( ), recall ( ) and F-score ( ) values 
(Table 3). For the case of Normal spectra, PCA+ICA, LE 
and the proposed DWT method obtained       
meaning that all of the Normal spectra were perfectly 
separated without any false positives (    ) and false 
negatives (    ). PCA also obtained a precision of 1 but 
its recall rate of       is lower, as it misclassified 8 
Normal spectra (    ). For the case of GIV spectra, 
PCA, PCA+ICA and LE produce      each with       . The proposed DWT method produced      
and thus resulted in a better       . On the other hand, all 
methods missed 6 GIV spectra with       . For the case 
of GII spectra, the proposed DWT method outperformed the 
remaining methods both in terms of precision and recall. 
This method produced the least number of incorrect 
classifications (            ) thus obtaining the best   
(Table 3), but incorrectly classified one GII spectrum as a 
GIV spectrum, and six GIV spectra as GII spectra. In this 
case, the incorrect clustering of GIV spectra in the GII 
cluster, show spectral characteristics that make it non-trivial 
to distinguish them as GIV spectra. Moreover, the proposed 
DWT method showed the highest          , 
demonstrating better separability of clusters of the feature,   , than for those extracted using PCA, PCA+ICA and LE 
methods (Table 3). In terms of     LE shows the smallest 
variation in the silhouette values (Table 3).  
IV. DISCUSSION 
Overall, the experimental results suggest that our wavelet 
based feature extraction (by whole-spectral or sub-spectral 
analysis) and clustering provides the maximum accuracy of 
94.8% for tissue separation, which demonstrates an 
improvement compared to the PCA, PCA+ICA, and 
nonlinear LE methods. In addition, our accuracies for 
distinguishing GII from GIV tumours using DWT and 
hierarchical clustering compares well to the results of 
Garcia-Gomez et al. [25], who achieved 92.58% accuracy 
for distinguishing low from high grade gliomas by 
combining data from SV long echo and short echo data, 
which would be difficult to routinely achieve with MRS 
acquisitions due to time limits for patient scanning. A more 
recent approach [26] used Non-negative Matrix 
Factorisation (NMF) to accomplish the feature extraction 
task for SV tumour spectra. However, NMF methods 
inevitably converge to local minima and various 
initialisations provide different dimensionality reduction; 
therefore, NMF requires an elaborate initialisation scheme as 
discussed in previous investigation [26]. In addition, we 
achieved similar BER (0.078 in Table 2) using an 
unsupervised learning based clustering as Ortega-Martorell 
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et al. [26] obtained with a supervised learning based 
framework. The short echo SV MRS data used in the current 
study is a subset of the INTERPRET and eTUMOUR project 
data used in [25] and [26]  and are compatible for acquisition 
parameters and ground truth diagnosis from the 
histopathological and clinical information. 
 Interestingly, our results on whole spectra showed large 
variance of the clustering accuracy with respect to different 
decomposition levels. The decomposition of the MRS 
signals using multiple levels of resolution present with much 
larger variance in accuracy compared to the sub-spectra 
analysis while varying the window sizes. Suggesting sub-
spectral DWT analysis may be more stable. In addition, 
average results of using different basis functions of the sub-
spectral analysis are superior to the average results of using 
the whole spectra (Figure 3). However, the maximum 
clustering accuracy determined from the whole spectra is 
94.8% using the Coif1 basis function and 6 levels of 
decomposition, which is still superior to PCA, PCA+ICA 
and nonlinear LE methods. Nevertheless, the minimum 
clustering accuracy is 40.3% using Coif1 basis function with 
3 levels of decomposition indicating that DWT analysis on 
whole spectra is unstable with respect to decomposition 
levels. 
 
 
 
Figure 4: (a) FLAIR image of the misclassified GII case; (b) T2-weighted 
image of one misclassified GIV case; (c) Blue curve: SV MRS signal of (a); 
(d) Blue curve: SV MRS signal of (b); Planned SV MRS acquisitions are 
shown in cyan boxes overlaid on structural MRI images. 
 
    The improvement provided by the proposed DWT method 
is a better separation between GII and GIV tumours. There is 
one misclassified GII spectrum as GIV (Figure 4(a) and (c)), 
and 6 misclassified GIV as GII (one example shown in 
Figure 4(b) and (d)). The one misclassified GII spectrum has 
unexpectedly high peaks of Lipid (Figure 4(c)). In contrast, 
all misclassified GIV spectra have very low Lipid signal, 
and so resemble GII spectra. The misclassification of these 
tumour spectra may be due to the fact that our ground truth 
is defined by local biopsy or resected tumour samples that 
do not accurately represent the tissue that has been 
investigated by MRS. The tumour biopsy samples used for 
histopathology have typical volumes in mm3, whereas the 
SV MRS data are acquired from a volume in cm3 [14]. In 
particular, the highest grade tumour cells observed in the 
biopsy determine the clinical assignation of tumour grade 
and may only represent a small proportion of the tissue in 
the MRS voxel. Additionally GIV tumours are frequently 
large heterogeneous masses that have areas of low-grade 
appearance by 1H MRS [27], and the most malignant region 
may not have been sampled by a single voxel placement. 
    Our analysis may have some potential limitations. As 
aforementioned, the whole-spectral analysis suffers from 
large variance of the clustering accuracy when 
decomposition levels of the DWT are varied. For the sub-
spectral analysis, we rely upon pre-definition of the key 
biochemical peaks, which require elaborate tuning prior to 
application of DWT. However, once the window sizes are 
fixed, more SV MRS data (i.e., more normal, GII, and GIV 
SV MRS data) may be added without retuning. In addition, 
there may be diagnostically useful contributions to the 
spectra from biochemicals with lower overall visibility. For 
example quantified levels of myo-inositol, glutathione, 
glutamate-glutamine have been used in previous tumour 
classification studies, metabolites whose major contributions 
to an MR spectrum are outside of our selected spectral 
regions [13], [18]. Our selection of five key biochemical 
used in this study may have certain subjectivity. 
Nevertheless, these metabolites and lipid peaks are well 
known and widely used, features to discriminate brain 
tumour grades. For example, Opstad et al. [18] indicated that 
Choline, Creatine, Lactate and Lipid (1.3 ppm) were the 
most discriminative for GII and GIV tumour, and NAA and 
Lipid (0.9 ppm) were useful for classifying normal spectra. 
Moreover, we only included GII and GIV patients for this 
study due to lack of reliable GIII MRS data. However, we 
can envisage a straightforward application of the current 
DWT based feature extraction and unsupervised clustering 
framework for SV MRS dataset incorporating GIII cases. 
 
V. CONCLUSIONS 
    To the best of our knowledge, this is the first study using 
DWT and unsupervised clustering to separate SV MRS data 
from different brain tumour types. We tested both DWT 
based whole-spectral and sub-spectral analysis, and we have 
concluded that a sub-spectral analysis is sufficient by using 
windowed key metabolites to distinguish different grades of 
the brain tumour. The achievement is threefold: (a) we 
compared different DWT settings including various wavelet 
basis functions for both whole-spectral and sub-spectral 
analysis, different window sizes for the sub-spectral 
analysis, and multiple levels of decomposition for the whole-
spectral analysis, and we have found that Coif1 wavelet 
obtained the best clustering results; (b) we compared DWT 
based sub-spectral analysis with DWT feature extraction on 
the whole spectra. Quantitative evidence show that our sub-
spectral analysis is more stable irrespective of the window 
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sizes selected for the key metabolites; (c) we also compared 
to conventional feature extraction methods such as PCA, 
PCA+ICA, and newly applied nonlinear LE algorithm, and 
the comparison demonstrated that both our DWT based 
whole-spectral and sub-spectral analysis can further improve 
the separation between GII and GIV tissue types while 
maintaining the accuracy of separating tumour spectra from 
normal brain spectra in controls. In summary, our DWT 
based feature extraction and hierarchical clustering produces 
promising brain tumour classification that has potential for 
analysis of larger multi-centre datasets and be applicable to 
automated analysis of the large datasets obtained in 
multivoxel 1H MRS using chemical shift imaging. 
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